Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Immunologic Response to Pneumococcal Polysaccharide Vaccine in Splenic Injury Patients

NCT02232191 is registered in ClinicalTrials.gov with University of California, Davis as lead sponsor.

NCT NCT02232191
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02232191 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Immunologic Response to Pneumococcal Polysaccharide Vaccine in Splenic Injury Patients
Lead sponsor
University of California, Davis
Phase
Phase 2
Overall status
Recruiting
Start date
December 31, 2014
Completion date
July 31, 2027
Enrollment
75 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

asplenia